Hilary Baldwin
Dermatology · Brooklyn, NYNPI 1962496265
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $1,080,318 of the $1,527,609 with a category attached, or 70.7%. 30 manufacturers reported payments, led by Sun Pharmaceutical Industries Inc. at 38.9% of the total. 2025 is the largest year on record at $317,662, 3.7 times the $87,027 reported in 2019. Among dermatology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,297 payments — averaging $1177.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$595K
- Galderma Laboratories, L.p.$449K
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$239K
- VYNE Pharmaceuticals Inc.$114K
- Almirall LLC$53K
- EPI Health, LLC$23K
- plus $55K from 24 others
Across 158 payments — averaging $3884.19 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Almirall LLC$538K
- Bausch Health US, LLC$76K
What the payments were for
- Consulting fees$284,66619%
- Speaking & faculty fees$1,080,31871%
- Travel & lodging$115,4178%
- Food & beverage$42,0863%
- Education$5,0050%
- Gifts$1170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 452 | $594,842 |
| Galderma Laboratories, L.p. | 372 | $449,250 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 192 | $238,969 |
| VYNE Pharmaceuticals Inc. | 90 | $113,506 |
| Almirall LLC | 47 | $53,380 |
| EPI Health, LLC | 24 | $22,834 |
| Arcutis Biotherapeutics, Inc. | 8 | $12,155 |
| LNHC, Inc | 12 | $8,696 |
| Pfizer | 15 | $7,915 |
| Glenmark Therapeutics Inc. | 3 | $4,780 |
| Sanofi | 1 | $3,992 |
| Journey Medical Corporation | 5 | $3,604 |
| Novartis | 1 | $2,250 |
| AbbVie(2 entities) | 6 | $1,924 |
| Dermira, Inc. | 8 | $1,874 |
| Sanofi Pasteur Inc. | 1 | $1,624 |
| Biofrontera Inc. | 2 | $1,600 |
| Strata Skin Sciences, Inc. | 4 | $1,507 |
| Mayne Pharma Commercial LLC | 32 | $1,413 |
| Encore Dermatology Inc. | 1 | $1,000 |
| Janssen Scientific Affairs, LLC | 1 | $146 |
| Bausch Health US, LLC | 3 | $88 |
| UCB, Inc. | 4 | $83 |
| Lilly USA, LLC | 3 | $46 |
| Prugen, Inc. Pharmaceuticals | 3 | $39 |
| Sebela Pharmaceuticals Inc. | 2 | $29 |
| Johnson & Johnson | 2 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $13 |
| DUSA Pharmaceuticals, Inc. | 1 | $13 |
| Aclaris Therapeutics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Winlevi$547,926
- AKLIEF$214,816
- ABSORICA LD$141,371
- Cabtreo$105,352
- ARAZLO$96,508
- TWYNEO$92,783
- ORACEA$92,633
- EPSOLAY$90,536
- ZILXI$68,800
- EPIDUO FORTE$52,602
- AMZEEQ$43,658
- SOOLANTRA$37,255
- Seysara$33,323
- Rhofade$17,470
- Sitavig$14,995
- Cloderm$14,995
- Minolira 105mg$14,995
- Minolira 135mg$14,995
- DUOBRII$12,275
- Klisyri$11,700
How this compares
$1,527,609 in reported general payments places this provider in the 95th percentile of 1,151 dermatology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 15 | $10,845 |
| Imiquimod | 27 | $1,399 |
| Doxycycline Monohydrate | 25 | $875 |
| Clobetasol Propionate | 16 | $823 |
| Doxycycline Hyclate | 22 | $461 |
| Mometasone Furoate | 17 | $335 |
| CiclopiroxCiclopirox Olamine | 19 | $283 |
| Minoxidil | 27 | $182 |
| Desoximetasone | 11 | $164 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia | $238,969 | $10,84515 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,151 dermatology providers in New York.
Other dermatology in Brooklyn
- Steven BaranowitzBrooklyn$625K
- Susan BardBrooklyn$425K
- Nanette SilverbergBrooklyn$337K
- Alexandra GolantNew York$3.6M
- David CohenNew York$3M
- Michael CameronNew York$2.6M
- Saakshi KhattriNew York$2.4M
- Amy WechslerNew York$2.4M
- Jeffrey WeinbergKew Gardens$2.3M
- Joshua ZeichnerNew York$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.